Zyno Medical LLC

Zyno Medical LLC
Product: infusion pumps
Date:12/5/2016

Failure to establish and maintain procedures to control product that does not conform to specified requirements, and to address the identification, documentation, evaluation, segregation, and disposition of nonconforming product, as required by 21 CFR 820.90(a). For example:
Your firm did not open a non-conforming report (NCR) on 7/30/15, when over (b)(4) Z-800F infusion pumps had a flow rate outside your specification when tested at Test Station (b)(4).
Your NCR dated 8/12/15 documented that (b)(4) Z-800F and (b)(4) Z-800 Infusion Pumps received from your contract manufacturer had the wrong software installed. The rework performed on these units was not documented.
Your response is not adequate to address the above violation. We acknowledge you will be updating your procedures, re-trained your staff and performed a retrospective review of previous NCR activities. In response to the Warning Letter, you should provide us with a summary of your retrospective review as well as a description of any required corrective actions taken as the result of your review. We will need to verify during a re-inspection that your revised procedures will be implemented effectively.

5. Failure to establish and maintain procedures for acceptance activities that include inspections, tests, or other verification activities, as required by 21 CFR 820.80(a). For example, a review of acceptance testing performed at your facility revealed the following inconsistencies:
The IFU for your Z-800 Infusion Pump recommends that the battery be replaced after one to two years, however, your repair and maintenance work instructions indicates that if the pump is less than (b)(4) years old, the battery does not need to be replaced.
The Flow Rate Accuracy testing for new pumps includes a total test time of (b)(4) minutes but the Flow Rate Accuracy testing for pumps returned for service, includes only (b)(4) minutes total test time.
The Z-800 Testing & Calibration Work Instruction does not include instructions to verify that the current software version is installed on devices received from your contract manufacturer.

FDA District: New England District Office

About the author

Amy enjoys researching and writing about developments in medical technology and how that intersects with US law. She received her J.D. from the University of Florida Levin College of Law in 2020 and now works as a Regulatory Associate for SoftwareCPR®, a general-purpose regulatory consulting firm that is recognized globally for their expertise with standards and national regulations pertaining to medical device, mobile medical app, and HealthIT software.

62304 Software Training Course – February 23-25, 2021

IEC 62304 and Emerging Standards and FDA Expectations for Medical Device and Health IT Software – Virtual

This very popular 3-day course provides a clear understanding of applying IEC 62304 standard for medical device software and much more. The course compares and contrasts 62304 with FDA expectations and discusses approaches for alignment. In addition, participants will learn of other relevant standards and technical reports pertinent to medical device software, HealthIT, medical mobile apps, and Software as a Medical Device (SaMD) products (e.g., 82304, 80002-1, 14971, 80001-2-x, 62366).

Participants will gain practical advice and pragmatic experience with all types of medical software. Participants will leave with a clear understanding of how to effectively and efficiently integrate 62304 compliance into their software development lifecycle (SDLC).

Register (click):  EventZilla Registration Site

Need info?  Email us at training@softwarecpr.com

Corporate Office

15148 Springview St
Tampa, FL 33624
USA
+1-781-721-2921
Partners located in the US (CA, FL, MA, MN) and Italy.